Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2013 | 12-2012 | |
| Operating Expenses | 5,451 | 0 |
| Operating Income | -5,451 | N/A |
| Interest Expense | 353 | 0 |
| Other Income | 232 | 0 |
| Pre-tax Income | -5,572 | 0 |
| Net Income Continuous | -5,572 | N/A |
| Net Income | $-5,572 | $N/A |
| EPS Basic Total Ops | -1,091.24 | N/A |
| EPS Basic Continuous Ops | -1,091.20 | N/A |
| EPS Diluted Total Ops | -1,091.24 | N/A |
| EPS Diluted Continuous Ops | -1,091.20 | N/A |
| EBITDA(a) | $-5,380 | $N/A |